131 related articles for article (PubMed ID: 6511725)
1. Diagnostic efficacy of estimating fibrinogen/fibrin degradation products in pleural and peritoneal effusion fluids.
Dube B; Narayanan R; Dube RK; Singh VP
J Assoc Physicians India; 1984 Jun; 32(6):493-5. PubMed ID: 6511725
[No Abstract] [Full Text] [Related]
2. [Differential examination of the serous fluid and key points in clinical tests].
Takayanagi N
Rinsho Byori; 1983 Sep; 31(9):927-33. PubMed ID: 6663768
[No Abstract] [Full Text] [Related]
3. [Relation between fibrin/fibrinogen degradation products in malignant fluids and the fibrinolytic activity of the peritoneum].
Takahashi M; Yoshida K; Kano K; Machida T; Nakamura Y; Miura Y; Miura N; Kanno S
Gan No Rinsho; 1986 Dec; 32(15):1945-9. PubMed ID: 3806965
[TBL] [Abstract][Full Text] [Related]
4. [Detection of D -dimer in pleural effusion].
Lü YD; Chen P; Xu M
Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):71-2. PubMed ID: 12212257
[TBL] [Abstract][Full Text] [Related]
5. Role of immunoperoxidase staining in serous effusions.
Sarker AB; Hoshida Y; Nose S
Bangladesh Med Res Counc Bull; 1993 Aug; 19(2):33-8. PubMed ID: 8161332
[TBL] [Abstract][Full Text] [Related]
6. [Fluid collection in the thorax and abdomen].
Gresser U
Bildgebung; 1987-1989; 56 Suppl 2():48-53. PubMed ID: 3078260
[No Abstract] [Full Text] [Related]
7. [Identification of fibrinogen or fibrin degradation products in the ascitic fluid].
Kolodie L; Detante J; Rachail M
Nouv Presse Med; 1978 Feb; 7(8):665. PubMed ID: 417295
[No Abstract] [Full Text] [Related]
8. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
[TBL] [Abstract][Full Text] [Related]
9. D-dimer levels in pleural effusions.
Dikensoy O; Stathopoulos GT; Zhu Z; Light RW
Respir Med; 2006 Aug; 100(8):1337-41. PubMed ID: 16427265
[TBL] [Abstract][Full Text] [Related]
10. [Degradation products of fibrinogen in synovial fluid].
Punzi L; Bertaglia E; Pengo V; Fiocco U; Todesco S
Boll Soc Ital Biol Sper; 1979 Aug; 55(16):1576-80. PubMed ID: 553542
[TBL] [Abstract][Full Text] [Related]
11. [Importance of the determination of adenosine deaminase in pleuro-peritoneal effusions].
Cortejoso García R; Rodrigo Calabia MP; Rodríguez Rodríguez MA; Peñas Maldonado L
Med Clin (Barc); 1987 May; 88(20):826. PubMed ID: 3600081
[No Abstract] [Full Text] [Related]
12. [Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect].
Marsan C; Gaulier A; Sabatier P; Garcia R
Arch Anat Cytol Pathol; 1993; 41(5-6):223-8. PubMed ID: 8135583
[TBL] [Abstract][Full Text] [Related]
13. [Differential diagnostic importance of lactate dehydrogenase in exudates].
Busse K; Einert HJ
Med Klin; 1966 Sep; 61(39):1535-7. PubMed ID: 5998890
[No Abstract] [Full Text] [Related]
14. The lactate dehydrogenases in malignant and non-malignant diseases.
Oladipo OO; Ajala MO; Afonja OA
Niger Postgrad Med J; 2002 Mar; 9(1):1-6. PubMed ID: 11932752
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human immunodeficiency virus infection: its impact on the diagnostic yields in exudative pleural effusions at the Kenyatta National Hospital, Nairobi.
Owino EA; McLigeyo SO; Gathua SN; Nyong'o A
East Afr Med J; 1996 Sep; 73(9):575-8. PubMed ID: 8991236
[TBL] [Abstract][Full Text] [Related]
16. [Products of fibrinogen degradation in cirrhotic ascites. Value of their assay].
Hadchouel P; Bognel JC; Caillet R; Perotin B; Hebert D
Nouv Presse Med; 1980 Jun; 9(26):1844. PubMed ID: 7393737
[No Abstract] [Full Text] [Related]
17. Fibrin/fibrinogen degradation products in pleural exudate.
Astedt B; Adielsson G; Mattsson W
Lancet; 1976 Aug; 2(7982):414. PubMed ID: 73867
[No Abstract] [Full Text] [Related]
18. [Analysis of fibrinogen in the ascitic and pleural fluids and its clinicopathological significance].
Takayanagi N; Iwaki M
Rinsho Byori; 1971 Nov; 19(11):797-801. PubMed ID: 5168418
[No Abstract] [Full Text] [Related]
19. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
Collatos C; Barton MH; Prasse KW; Moore JN
J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of ascitic fluid FDP and fibrinolytic activity assay].
Lu XG; Chen CS; Ye ZY
Zhonghua Nei Ke Za Zhi; 1987 Sep; 26(9):530-2, 565. PubMed ID: 3450474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
